✦ LIBER ✦

Peginterferon α-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients

✍ Scribed by Makoto Kuboki; Shiro Iino; Tadao Okuno; Masao Omata; Kendo Kiyosawa; Hiromitsu Kumada; Norio Hayashi; Takahiro Sakai

Book ID: 108951298
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 174 KB
Volume: 0
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2007.04834.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predicting sustained virological respons

Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) plus ribavirin

✍ Eric Snoeck; Janet R. Wade; Frank Duff; Matthew Lamb; Karin Jorga 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 739 KB

Early virologic response after peginterf

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

✍ A. M. Di Bisceglie; R. H. Ghalib; F. M. Hamzeh; V. K. Rustgi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Efficacy and safety of peginterferon alf

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

✍ Savino Bruno; Mitchell L. Shiffman; Stuart K. Roberts; Edward J. Gane; Diethelm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB 👁 1 views

The objective of this study is to determine the efficacy and safety of peginterferon alfa-2a (40 KD)/ribavirin in patients with advanced fibrosis. Data from 341 genotype 1/4 patients (99 with bridging fibrosis/cirrhosis) treated for 48 weeks and 1547 genotype 2/3 patients (380 with bridging fibrosis

The economics of treating chronic hepati

The economics of treating chronic hepatitis C patients with peginterferon α-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase

✍ J. Hornberger; P. Farci; D. Prati; S. Zeuzem; J. Green; K. K. Patel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Comparison of a 6-month course peginterf

Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan

✍ S.-D. Lee; M.-L. Yu; P.-N. Cheng; M.-Y. Lai; Y.-C. Chao; S.-J. Hwang; W.-Y. Chan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Re-treatment of chronic hepatitis C pati

Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin

✍ C. Berg; F. L. Goncales Jr; D. E. Bernstein; H. Sette Jr; J. Rasenack; M. Diago; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB